Business Description
Q32 Bio Inc
NAICS : 541714
SIC : 2833
ISIN : US7469641051
Description
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.5 | |||||
| Equity-to-Asset | -3.89 | |||||
| Debt-to-Equity | -0.28 | |||||
| Debt-to-EBITDA | -1.98 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.93 | |||||
| 9-Day RSI | 61.99 | |||||
| 14-Day RSI | 65.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.04 | |||||
| Quick Ratio | 2.04 | |||||
| Cash Ratio | 1.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 176.03 | |||||
| Net Margin % | 184.61 | |||||
| FCF Margin % | -64.93 | |||||
| ROA % | -49.94 | |||||
| ROIC % | -46.56 | |||||
| ROC (Joel Greenblatt) % | -302.53 | |||||
| ROCE % | -412.11 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 82.17 | |||||
| Price-to-Free-Cash-Flow | 32.64 | |||||
| Price-to-Operating-Cash-Flow | 32.64 | |||||
| EV-to-EBIT | -13.83 | |||||
| EV-to-EBITDA | -13.9 | |||||
| EV-to-Revenue | -24.35 | |||||
| EV-to-FCF | 39.04 | |||||
| Earnings Yield (Greenblatt) % | -7.23 | |||||
| FCF Yield % | 3.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:QTTB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Q32 Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -14.662 | ||
| EPS (TTM) ($) | -2.269 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 65.18 | ||
| 14-Day ATR ($) | 2.138767 | ||
| 20-Day SMA ($) | 24.558 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 15.07 - 30.92 | ||
| Shares Outstanding (Mil) | 11.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Q32 Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Q32 Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Q32 Bio Inc Frequently Asked Questions
What is Q32 Bio Inc(QTTB)'s stock price today?
The current price of QTTB is $26.44. The 52 week high of QTTB is $30.92 and 52 week low is $15.07.
When is next earnings date of Q32 Bio Inc(QTTB)?
The next earnings date of Q32 Bio Inc(QTTB) is .
Does Q32 Bio Inc(QTTB) pay dividends? If so, how much?
Q32 Bio Inc(QTTB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers